Correlation Between Maxigen Biotech and SciVision Biotech

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and SciVision Biotech, you can compare the effects of market volatilities on Maxigen Biotech and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and SciVision Biotech.

Diversification Opportunities for Maxigen Biotech and SciVision Biotech

-0.5

Correlation Coefficient

Maxigen Biotech  SciVision Biotech

Very good diversification

The 3 months correlation between Maxigen and SciVision is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and SciVision Biotech go up and down completely randomly.

Pair Corralation between Maxigen Biotech and SciVision Biotech

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 0.78 times more return on investment than SciVision Biotech. However, Maxigen Biotech is 1.29 times less risky than SciVision Biotech. It trades about 0.18 of its potential returns per unit of risk. SciVision Biotech is currently generating about -0.06 per unit of risk. If you would invest  4,455  in Maxigen Biotech on September 25, 2024 and sell it today you would earn a total of  245.00  from holding Maxigen Biotech or generate 5.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Maxigen Biotech  vs.  SciVision Biotech

Maxigen Biotech

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

SciVision Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Maxigen Biotech and SciVision Biotech

The main advantage of trading using opposite Maxigen Biotech and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.

The idea behind Maxigen Biotech and SciVision Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.